{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T02:58:12Z","timestamp":1782788292901,"version":"3.54.5"},"reference-count":95,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Due to the fact that statins are among the most high-demand therapeutic agents used for the treatment and prevention of the most common cardiovascular diseases, a significant amount of research is focused on these drugs. As a result, the study and discovery of new effects in statin drugs continues. Research methods are constantly being improved in terms of their sensitivity and specificity, which leads to a change in ideas. In addition to the main lipid-lowering effect, statins have a number of additional effects, which can be conditionally divided into positive (pleiotropic) and negative (side effects). Moreover, information about many of the pleiotropic effects of statins is controversial and may subsequently change as new data become available. To a large extent, this is due to the introduction of new and the improvement of old methods of study: clinical, laboratory and morphological ones. Recent studies report the possibility of statins having potential cardiotoxic properties, which is expressed by an increase in the concentration of highly sensitive cardiac troponins, as well as various adverse changes in cardiac myocytes at the ultrastructural and molecular levels. This paper discusses possible mechanisms of statin cardiotoxicity. This narrative review is based on an analysis of publications in the Medline, PubMed, PubMed Central and Embase databases. The terms \u201cstatins\u201d, \u201ctroponin\u201d, \u201ctroponin I\u201d, \u201ctroponin T\u201d in combination with \u201ccardiotoxicity\u201d, \u201cfalse positive\u201d, \u201cmechanisms of increase\u201d, \u201cpathophysiological mechanisms\u201d, \u201coxidative stress\u201d and \u201ccardiomyocyte apoptosis\u201d were used to search publications.<\/jats:p>","DOI":"10.3390\/jcdd9110403","type":"journal-article","created":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T04:13:36Z","timestamp":1669004016000},"page":"403","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Review of Recent Laboratory and Experimental Data on Cardiotoxicity of Statins"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2712-0227","authenticated-orcid":false,"given":"Aleksey M.","family":"Chaulin","sequence":"first","affiliation":[{"name":"Department of Histology and Embryology, Samara State Medical University, 443099 Samara, Russia"},{"name":"Department of Cardiology and Cardiovascular Surgery, Samara State Medical University, 443099 Samara, Russia"},{"name":"Research Institute of Cardiology, Samara State Medical University, 443099 Samara, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,19]]},"reference":[{"key":"ref_1","first-page":"417","article-title":"Anichkov and his theory of atherosclerosis","volume":"33","author":"Konstantinov","year":"2006","journal-title":"Tex. Heart Inst. J."},{"key":"ref_2","first-page":"150","article-title":"To the 130th anniversary since the birth of the prominent pathologist N.N. Anichkov, academician of USSR Academy of sciences and Academy of medical sciences","volume":"3","author":"Pigarevsky","year":"2015","journal-title":"Patol. Fiziol. Eksp. Ter."},{"key":"ref_3","first-page":"3","article-title":"Anichkova na sovremennom \u00e9tape ucheniia ob ateroskleroze [Development of the ideas of N. N. Anichkov at the present stage of our knowledge about atherosclerosis]","volume":"37","author":"Klimov","year":"1975","journal-title":"Arkh Patol."},{"key":"ref_4","first-page":"202","article-title":"History of Statins Development. New Prospects","volume":"11","author":"Dreeva","year":"2017","journal-title":"Med. Counc."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0022-2275(20)41379-3","article-title":"The discovery and development of HMG-CoA reductase inhibitors","volume":"33","author":"Endo","year":"1992","journal-title":"J. Lipid. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.mcna.2017.03.001","article-title":"Statins for Primary Prevention of Cardiovascular Disease","volume":"101","author":"Kazi","year":"2017","journal-title":"Med. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11883-019-0793-7","article-title":"Role of Statin Therapy in Primary Prevention of Cardiovascular Disease in Elderly Patients","volume":"21","author":"Strandberg","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s40256-019-00391-z","article-title":"Statins, LDL Cholesterol Control, Cardiovascular Disease Prevention, and Atherosclerosis Progression: A Clinical Perspective","volume":"20","author":"Nesti","year":"2019","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.jacl.2017.05.016","article-title":"Long-term treatment adherence to the proprotein convertase subtilisin\/kexin type 9 inhibitor alirocumab in 6 ODYSSEY Phase III clinical studies with treatment duration of 1 to 2 years","volume":"11","author":"Farnier","year":"2017","journal-title":"J. Clin. Lipidol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.5551\/jat.55400","article-title":"An Update on the Role of PCSK9 in Atherosclerosis","volume":"27","author":"Yurtseven","year":"2020","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_13","first-page":"45","article-title":"PCSK-9: Modern views about biological role and possibilities of use as a diagnostic marker for cardiovascular diseases. Part 1. Kardiologiya: Novosti, mneniya, obuchenie","volume":"7","author":"Chaulin","year":"2019","journal-title":"Cardiol. News Opin. Train."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Arrieta, A., Page, T.F., Veledar, E., and Nasir, K. (2017). Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0169761"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chaulin, A.M. (2021). Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 1. Life, 11.","DOI":"10.3390\/life11090914"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/eurheartj\/ehq456","article-title":"Troponin elevation in coronary vs. non-coronary disease","volume":"32","author":"Agewall","year":"2010","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chaulin, A.M. (2021). Elevation Mechanisms and Diagnostic Consideration of Cardiac Troponins under Conditions Not Associated with Myocardial Infarction. Part 2. Life, 11.","DOI":"10.3390\/life11111175"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.2174\/1874467214666210210123206","article-title":"Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage","volume":"14","author":"Gorabi","year":"2021","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/07853890310001294","article-title":"A novel pleiotropic effect of statins: Prevention of cardiac hypertrophy by cholesterol-independent mechanisms","volume":"35","author":"Nakagami","year":"2003","journal-title":"Ann. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/MOL.0b013e3283453e41","article-title":"Mechanisms for the anti-inflammatory effects of statins","volume":"22","author":"Bu","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.33549\/physiolres.932420","article-title":"Pleiotropic Effects of Simvastatin Are Associated With Mitigation of Apoptotic Component of Cell Death Upon Lethal Myocardial Reperfusion-Induced Injury","volume":"61","author":"Rajtik","year":"2012","journal-title":"Physiol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"14652","DOI":"10.1038\/s41598-018-32376-4","article-title":"Simvastatin Protects Cardiomyocytes Against Endotoxin-induced Apoptosis and Up-regulates Survivin\/NF-\u03baB\/p65 Expression","volume":"8","author":"Gajanin","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zinellu, A., and Mangoni, A.A. (2021). A Systematic Review and Meta-Analysis of the Effect of Statins on Glutathione Peroxidase, Superoxide Dismutase, and Catalase. Antioxidants, 10.","DOI":"10.3390\/antiox10111841"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.5551\/jat.24398","article-title":"Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders","volume":"21","author":"Lim","year":"2014","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10552-021-01487-1","article-title":"Statins to mitigate cardiotoxicity in cancer patients treated with anthracyclines and\/or trastuzumab: A systematic review and meta-analysis","volume":"32","author":"Obasi","year":"2021","journal-title":"Cancer Causes Control"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"103","DOI":"10.20996\/1819-6446-2022-02-11","article-title":"Cardioprotective Strategies for Doxorubicin-induced Cardiotoxicity: Present and Future","volume":"18","author":"Chaulin","year":"2022","journal-title":"Ration. Pharmacother. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0021-9150(03)00053-4","article-title":"High oxidative stress in patients with stable coronary heart disease","volume":"168","author":"Weinbrenner","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ihj.2015.03.016","article-title":"Elevated oxidative stress among coronary artery disease patients on statin therapy: A cross sectional study","volume":"67","author":"Palazhy","year":"2015","journal-title":"Indian Heart J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.toxlet.2012.10.010","article-title":"Prooxidative toxicity and selenoprotein suppression by cerivastatin in muscle cells","volume":"215","author":"Fuhrmeister","year":"2012","journal-title":"Toxicol. Lett."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1124\/mol.108.053678","article-title":"Statin-Induced Liver Injury Involves Cross-Talk between Cholesterol and Selenoprotein Biosynthetic Pathways","volume":"75","author":"Kromer","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/HCO.0000000000000874","article-title":"Statin intolerance: New data and further options for treatment","volume":"36","author":"Diaconu","year":"2021","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_32","first-page":"254","article-title":"Hepatotoxicity associated with statins","volume":"68","author":"Karahalil","year":"2017","journal-title":"Arch. Ind. Hyg. Toxicol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11883-019-0780-z","article-title":"Diabetogenic Action of Statins: Mechanisms","volume":"21","author":"Carmena","year":"2019","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2015.194","article-title":"The diabetogenic action of statins\u2014mechanisms and clinical implications","volume":"12","author":"Betteridge","year":"2015","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1177\/2047487314550804","article-title":"Muscle- and skeletal-related side-effects of statins: Tip of the iceberg?","volume":"23","author":"Auer","year":"2014","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ccl.2015.02.008","article-title":"Statins and Cognitive Side Effects","volume":"33","author":"Hudani","year":"2015","journal-title":"Cardiol. Clin."},{"key":"ref_37","unstructured":"(2022, June 27). Available online: https:\/\/www.nobelprize.org\/prizes\/chemistry\/1965\/woodward\/facts\/."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/0002-8703(87)90645-4","article-title":"Cardiac-specific troponin-l radioimmunoassay in the diagnosis of acute myocardial infarction","volume":"113","author":"Cummins","year":"1987","journal-title":"Am. Heart J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/0022-2828(89)90680-9","article-title":"Enzyme linked immuno assay of cardiac troponin T for the detection of acute myocardial infarction in patients","volume":"21","author":"Katus","year":"1989","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2147\/VHRM.S300002","article-title":"Cardiac Troponins: Contemporary Biological Data and New Methods of Determination","volume":"17","author":"Chaulin","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrcardio.2017.48","article-title":"High-sensitivity assays for troponin in patients with cardiac disease","volume":"14","author":"Westermann","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/VHRM.S315376","article-title":"Clinical and Diagnostic Value of Highly Sensitive Cardiac Troponins in Arterial Hypertension","volume":"17","author":"Chaulin","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cca.2018.08.015","article-title":"Ultrasensitive quantification of cardiac troponin I by a Single Molecule Counting method: Analytical validation and biological features","volume":"486","author":"Gaze","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.jacc.2013.12.032","article-title":"Age- and Sex-Dependent Upper Reference Limits for the High-Sensitivity Cardiac Troponin T Assay","volume":"63","author":"Gore","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.clinbiochem.2017.11.003","article-title":"Sex-specific 99th percentiles derived from the AACC Universal Sample Bank for the Roche Gen 5 cTnT assay: Comorbidities and statistical methods influence derivation of reference limits","volume":"52","author":"Trupp","year":"2018","journal-title":"Clin. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1373\/clinchem.2018.298059","article-title":"Global Adoption of High-Sensitivity Cardiac Troponins and the Universal Definition of Myocardial Infarction","volume":"65","author":"Anand","year":"2019","journal-title":"Clin. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.15829\/1560-4071-2020-4061","article-title":"Circadian rhythms of cardiac troponins: Mechanisms and clinical significance","volume":"25","author":"Chaulin","year":"2020","journal-title":"Russ. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Chen, J.-Y., Lee, S.-Y., Li, Y.-H., Lin, C.-Y., Shieh, M.-D., and Ciou, D.-S. (2020). Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus. J. Clin. Med., 9.","DOI":"10.3390\/jcm9123917"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.22514\/SV133.062017.13","article-title":"Urine high sensitive Troponin I measuring in patients with hypertension","volume":"13","author":"Pervan","year":"2017","journal-title":"Signa Vitae\u2014A J. Intensiv. Care Emerg. Med."},{"key":"ref_50","first-page":"180","article-title":"Salivary high-sensitivity cardiac troponin T levels in patients with acute myocardial infarction","volume":"19","author":"Riahi","year":"2012","journal-title":"Oral Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"66","DOI":"10.18087\/cardio.2019.11.n414","article-title":"Clinical and Diagnostic Value of Cardiac Markers in Human Biological Fluids","volume":"59","author":"Chaulin","year":"2019","journal-title":"Kardiologiia"},{"key":"ref_52","first-page":"354","article-title":"Possibility of using saliva as a diagnostic test material in cardiovascular diseases","volume":"68","author":"Bachanek","year":"2015","journal-title":"Wiad. Lek."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.15829\/1560-4071-2020-3814","article-title":"Concentration of high-sensitivity cardiac troponin I in the oral fluid in patients with acute myocardial infarction: A pilot study","volume":"25","author":"Chaulin","year":"2020","journal-title":"Russ. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e0305","DOI":"10.15275\/rusomj.2020.0305","article-title":"Pathophysiological mechanisms of cardiotoxicity in chemotherapeutic agents","volume":"9","author":"Chaulin","year":"2020","journal-title":"Russ. Open Med. J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00392-017-1152-8","article-title":"Circadian rhythm of blood cardiac troponin T concentration","volume":"106","author":"Fournier","year":"2017","journal-title":"Clin. Res. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.cca.2020.02.004","article-title":"Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects","volume":"504","author":"Zaninotto","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e0311","DOI":"10.15275\/rusomj.2021.0311","article-title":"Experimental Modeling Of Hypothyroidism: Principles, Methods, Several Advanced Research Directions In Cardiology","volume":"10","author":"Chaulin","year":"2021","journal-title":"Russ. Open Med. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"23","DOI":"10.18087\/cardio.2506","article-title":"Circadian rhythms of thyroid hormones in patients with ischemic heart disease, arterial hypertension, and atrial fibrillation","volume":"59","author":"Tsareva","year":"2019","journal-title":"Kardiologiia"},{"key":"ref_59","first-page":"79","article-title":"On the potential effect of circadian rhythms of cardiac troponins on the diagnosis of acute myocardial infarction","volume":"17","author":"Chaulin","year":"2021","journal-title":"Signa Vitae\u2014J. Intensiv. Care Emerg. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11739-017-1612-1","article-title":"Cardiac biomarkers of acute coronary syndrome: From history to high-sensitivity cardiac troponin","volume":"12","author":"Garg","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Chaulin, A.M. (2021). Cardiac Troponins Metabolism: From Biochemical Mechanisms to Clinical Practice (Literature Review). Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222010928"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/emermed-2017-206812","article-title":"Understanding cardiac troponin part 1: Avoiding troponinitis","volume":"35","author":"Body","year":"2017","journal-title":"Emerg. Med. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2147\/VHRM.S327661","article-title":"The Main Causes and Mechanisms of Increase in Cardiac Troponin Concentrations Other Than Acute Myocardial Infarction (Part 1): Physical Exertion, Inflammatory Heart Disease, Pulmonary Embolism, Renal Failure, Sepsis","volume":"17","author":"Chauin","year":"2021","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Chaulin, A.M., and Sergeev, A.K. (2022). Modern concepts of the role of fine particles (PM 2.5) in the genesis of atherosclerosis and myocardial damage: Clinical and epidemiological data, the main pathophysiological mechanisms. Curr. Cardiol. Rev., in press.","DOI":"10.2174\/1573403X18666220817103105"},{"key":"ref_65","first-page":"3509","article-title":"Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats","volume":"41","author":"Yu","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-019-0760-z","article-title":"Molecular pathways involved in the cardioprotective effects of intravenous statin administration during ischemia","volume":"115","author":"Mendieta","year":"2019","journal-title":"Basic Res. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"105986","DOI":"10.1016\/j.phrs.2021.105986","article-title":"The cardioprotective actions of statins in targeting mitochondrial dysfunction associated with myocardial ischaemia-reperfusion injury","volume":"175","author":"Bland","year":"2021","journal-title":"Pharmacol. Res."},{"key":"ref_68","first-page":"380","article-title":"Impact of statin use on high sensitive troponin T levels with moderate exercise","volume":"74","author":"Cingirt","year":"2018","journal-title":"Acta Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehaa575","article-title":"2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"42","author":"Collet","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.11613\/BM.2019.010703","article-title":"Fast skeletal troponin I, but not the slow isoform, is increased in patients under statin therapy: A pilot study","volume":"29","author":"Trentini","year":"2018","journal-title":"Biochem. Med."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.amjcard.2014.05.047","article-title":"Impact of Statin Use on Exercise-Induced Cardiac Troponin Elevations","volume":"114","author":"Eijsvogels","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.jacc.2018.01.070","article-title":"Elevated Cardiac Troponin T in Patients with Skeletal Myopathies","volume":"71","author":"Schmid","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/jalm\/jfaa031","article-title":"Unexpected Troponin Elevation in a Patient Treated with Atorvastatin","volume":"5","author":"Collinson","year":"2020","journal-title":"J. Appl. Lab. Med."},{"key":"ref_75","first-page":"78","article-title":"Analytical Review of Modern Information on the Physiological and Pathochemical Mechanisms of the Release of Cardiospecific Proteins from Muscle Tissue, Methodology and Technologies of Their Research, Interpretation of the Results","volume":"11","author":"Chaulin","year":"2022","journal-title":"East. Eur."},{"key":"ref_76","first-page":"132","article-title":"The Main Causes and Mechanisms of the Formation of False Positive Results of Troponin Immunotests","volume":"11","author":"Chaulin","year":"2022","journal-title":"East. Eur."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/clinchem\/45.12.2129","article-title":"RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle","volume":"45","author":"Ricchiuti","year":"1999","journal-title":"Clin. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1309\/8KCL-UQRF-6EEL-36XK","article-title":"Expression of messenger RNA of the cardiac isoforms of troponin T and I in myopathic skeletal muscle","volume":"114","author":"Messner","year":"2000","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCGENETICS.115.001322","article-title":"Elevated Plasma Cardiac Troponin T Levels Caused by Skeletal Muscle Damage in Pompe Disease","volume":"9","author":"Wens","year":"2016","journal-title":"Circ. Cardiovasc. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.15829\/1728-8800-2021-2590","article-title":"High-sensitivity cardiac troponins: Detection and central analytical characteristics","volume":"20","author":"Chaulin","year":"2021","journal-title":"Cardiovasc. Ther. Prev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/j.jacc.2018.01.068","article-title":"Science Moves Slowly","volume":"71","author":"Jaffe","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"80","DOI":"10.14740\/jocmr4664","article-title":"False-Positive Causes in Serum Cardiac Troponin Levels","volume":"14","author":"Chaulin","year":"2022","journal-title":"J. Clin. Med. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1556\/650.2022.32296","article-title":"Main analytical characteristics of laboratory methods for the determination of cardiac troponins: A review from the historical and modern points of view","volume":"163","author":"Chaulin","year":"2022","journal-title":"Orv. Hetil."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1096\/fj.201800876R","article-title":"Atorvastatin, but not pravastatin, inhibits cardiac Akt\/mTOR signaling and disturbs mitochondrial ultrastructure in cardiac myocytes","volume":"33","author":"Godoy","year":"2018","journal-title":"FASEB J."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI43008","article-title":"MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice","volume":"120","author":"Zhang","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.12659\/MSM.897047","article-title":"Effect of Three Statins on Glucose Uptake of Cardiomyocytes and its Mechanism","volume":"22","author":"Jiang","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.yjmcc.2016.05.013","article-title":"Cholesterol is required for maintaining T-tubule integrity and intercellular connections at intercalated discs in cardiomyocytes","volume":"97","author":"Zhu","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2013.03.022","article-title":"Comparative effects of statins on murine cardiac gene expression profiles in normal mice","volume":"707","author":"Kumazaki","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-006-6235-z","article-title":"Toxicity of statins on rat skeletal muscle mitochondria","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Experientia"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1083\/jcb.150.6.1283","article-title":"Desmin Cytoskeleton Linked to Muscle Mitochondrial Distribution and Respiratory Function","volume":"150","author":"Milner","year":"2000","journal-title":"J. Cell Biol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0002-9440(10)63364-0","article-title":"Heterozygous Inactivation of the Vinculin Gene Predisposes to Stress-Induced Cardiomyopathy","volume":"165","author":"Ponrartana","year":"2004","journal-title":"Am. J. Pathol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/cddis.2012.61","article-title":"Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts","volume":"3","author":"Ghavami","year":"2012","journal-title":"Cell Death Dis."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: A review of proposed mechanisms","volume":"63","author":"Brault","year":"2014","journal-title":"Metabolism"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/9\/11\/403\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:21:46Z","timestamp":1760145706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/9\/11\/403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,19]]},"references-count":95,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["jcdd9110403"],"URL":"https:\/\/doi.org\/10.3390\/jcdd9110403","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,19]]}}}